JLabs NYC
Event Address

New York Genome Center
101 Sixth Avenue
New York, NY 10013
United States

Event Date

The Johnson & Johnson Innovation, JLABS (JLABS) Meet with… Series helps life sciences entrepreneurs, as well as the academic community, connect with potential partners including, corporate venture, VC's, Angels and other potential collaborators.


National Cancer Institute Small Business Innovation Research (NCI SBIR) Development Center Team Leader Andy Kurtz, and program director Todd Haim will be presenting funding opportunities, guidance on submitting competitive applications, and other resources for startups in cancer technology. Although the trends reflect improvements in cancer treatments and advances in technology have led to better tools for understanding, detecting, and diagnosing cancer, we still have work to do. In 2017, an estimated 1,688,780 new cases of cancer will be diagnosed in the United States. The NCI is poised to reduce the burden of cancer in this country and around the world at an accelerated pace.

Program directors will discuss the exciting new non-dilutive targeted funding opportunities in cancer focused technology development. They will explain the application and review process at the NIH to help small businesses submit stronger applications. Additionally, the presentation will highlight several initiatives run by NCI to facilitate the success of SBIR companies.

Following the presentation, selected companies will have the opportunity to meet one-on-one with NCI.*

 

Agenda

  • 9 - 9:30 AM | Registration Opens
  • 9:30 - 11:15 AM | Presentation and Q&A
    • NIH and NCI SBIR Overview and Initiatives
    • Funding Opportunities
    • Tips on Submitting Competitive Applications
    • Q&A
  • 11:30 - 12:45 PM | Networking & Lunch
  • 12:45 - 4 PM | One-on-one Meetings*

 

Register Now

 

*Companies must have applied for a one-on-one meeting ahead of time and been approved. Applications are due October 2, 2018.

To apply: Send an email to [email protected] and include your name, company name, and non-confidential one-page summary of your project.